Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Particle and Fibre Toxicology|July 11, 2019
Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm titanium dioxide nanoparticle aerosols in healthy adult rats after a single two-hour inhalation exposureWolfgang G Kreyling, Uwe Holzwarth, Carsten Schleh, et al.
Cancer Research|October 19, 2005
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibitionStuart Thomson, Elizabeth Buck, Filippo Petti, et al.
Oncotarget|October 2, 2015
Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case reportJad Alshami, Marie-Christine Guiot, Scott Owen, et al.
ACS Nano|August 8, 2018
Age-Dependent Rat Lung Deposition Patterns of Inhaled 20 Nanometer Gold Nanoparticles and their Quantitative Biokinetics in Adult RatsWolfgang G Kreyling, Winfried Möller, Uwe Holzwarth, et al.
Frontiers in Physiology|April 14, 2018
Intra-session and Inter-day Reliability of the Myon 320 Electromyography System During Sub-maximal ContractionsGraeme G Sorbie, Michael J Williams, David W Boyle, et al.
Nanotoxicology|March 15, 2017
Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1Wolfgang G Kreyling, Uwe Holzwarth, Nadine Haberl, et al.
Nanotoxicology|March 15, 2017
Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3Wolfgang G Kreyling, Uwe Holzwarth, Nadine Haberl, et al.
Nanotoxicology|March 15, 2017
Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2Wolfgang G Kreyling, Uwe Holzwarth, Carsten Schleh, et al.
Cancer Research|August 17, 2006
Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinibKendall D Carey, Andrew J Garton, Maria S Romero, et al.
Oncotargets and Therapy|April 15, 2022
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to AfatinibScott Owen, Scheryll Alken, Jad Alshami, et al.
Pageof 6